Article info

Download PDFPDF

Review
‘Should we stop or continue conventional synthetic (including glucocorticoids) and targeted DMARDs before surgery in patients with inflammatory rheumatic diseases?’

Authors

  1. Correspondence to Susan M Goodman, Department of Medicine, Hospital for Special Surgery, Weill Cornell Medicine, New York 10021, USA; Goodmans{at}hss.edu
View Full Text

Citation

Goodman SM, George MD
‘Should we stop or continue conventional synthetic (including glucocorticoids) and targeted DMARDs before surgery in patients with inflammatory rheumatic diseases?’

Publication history

  • Received April 20, 2020
  • Revision received June 3, 2020
  • Accepted June 5, 2020
  • First published July 27, 2020.
Online issue publication 
July 27, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.